OXFORD ASSET MANAGEMENT LLP - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 65 filers reported holding NEOS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$136,000
-40.6%
90,202
-41.8%
0.00%
-33.3%
Q3 2019$229,000
+69.6%
155,062
+47.9%
0.01%
+100.0%
Q2 2019$135,000
+13.4%
104,841
+129.4%
0.00%0.0%
Q1 2019$119,000
+197.5%
45,706
+89.1%
0.00%
+200.0%
Q4 2018$40,000
-99.0%
24,171
-93.9%
0.00%
-98.8%
Q4 2017$3,931,000395,1030.08%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,858,889$7,337,0005.11%
Proxima Capital Management, LLC 170,294$257,0000.77%
SPHERA FUNDS MANAGEMENT LTD. 3,530,731$5,331,0000.44%
Nantahala Capital Management 4,610,000$6,961,0000.21%
Wealthstar Advisors, LLC 73,295$111,0000.07%
Alambic Investment Management, L.P. 51,733$78,0000.06%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$151,0000.05%
BCS Wealth Management 29,520$45,0000.03%
Allred Capital Management, LLC 24,995$37,742,0000.02%
ALGERT GLOBAL LLC 34,254$52,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders